Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Notch signaling is necessary to maintain quiescence in adult muscle stem cells.

Bjornson CR, Cheung TH, Liu L, Tripathi PV, Steeper KM, Rando TA.

Stem Cells. 2012 Feb;30(2):232-42. doi: 10.1002/stem.773.

2.

Continuous administration of poloxamer 188 reduces overload-induced muscular atrophy in dysferlin-deficient SJL mice.

Suzuki N, Akiyama T, Takahashi T, Komuro H, Warita H, Tateyama M, Itoyama Y, Aoki M.

Neurosci Res. 2012 Feb;72(2):181-6. doi: 10.1016/j.neures.2011.10.005. Epub 2011 Oct 21.

PMID:
22044584
3.

Dysferlinopathy: spectrum of pathological changes in skeletal muscle tissue.

Gayathri N, Alefia R, Nalini A, Yasha TC, Anita M, Santosh V, Shankar SK.

Indian J Pathol Microbiol. 2011 Apr-Jun;54(2):350-4. doi: 10.4103/0377-4929.81636.

4.

Dysferlinopathies.

Amato AA, Brown RH Jr.

Handb Clin Neurol. 2011;101:111-8. doi: 10.1016/B978-0-08-045031-5.00007-4. Review.

PMID:
21496627
5.

Therapeutic approaches to muscular dystrophy.

Goyenvalle A, Seto JT, Davies KE, Chamberlain J.

Hum Mol Genet. 2011 Apr 15;20(R1):R69-78. doi: 10.1093/hmg/ddr105. Epub 2011 Mar 24. Review.

6.

Anti-TNF therapy using etanercept suppresses degenerative and inflammatory changes in skeletal muscle of older SJL/J mice.

Nemoto H, Konno S, Sugimoto H, Nakazora H, Nomoto N, Murata M, Kitazono H, Fujioka T.

Exp Mol Pathol. 2011 Jun;90(3):264-70. doi: 10.1016/j.yexmp.2011.02.003. Epub 2011 Feb 12.

PMID:
21324312
7.

Characterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotype.

Rayavarapu S, Van der Meulen JH, Gordish-Dressman H, Hoffman EP, Nagaraju K, Knoblach SM.

PLoS One. 2010 Sep 24;5(9):e12981. doi: 10.1371/journal.pone.0012981.

8.
9.

Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.

Paradas C, Llauger J, Diaz-Manera J, Rojas-García R, De Luna N, Iturriaga C, Márquez C, Usón M, Hankiewicz K, Gallardo E, Illa I.

Neurology. 2010 Jul 27;75(4):316-23. doi: 10.1212/WNL.0b013e3181ea1564. Epub 2010 Jun 23.

PMID:
20574037
10.

Dynamics of muscle fibre growth during postnatal mouse development.

White RB, Biérinx AS, Gnocchi VF, Zammit PS.

BMC Dev Biol. 2010 Feb 22;10:21. doi: 10.1186/1471-213X-10-21.

11.

The distribution and characterization of skeletal muscle lesions in dysferlin-deficient SJL and A/J mice.

Kobayashi K, Izawa T, Kuwamura M, Yamate J.

Exp Toxicol Pathol. 2010 Sep;62(5):509-17. doi: 10.1016/j.etp.2009.06.009. Epub 2009 Jul 16.

PMID:
19615872
12.

Focal adhesion kinase signaling regulates the expression of caveolin 3 and beta1 integrin, genes essential for normal myoblast fusion.

Quach NL, Biressi S, Reichardt LF, Keller C, Rando TA.

Mol Biol Cell. 2009 Jul;20(14):3422-35. doi: 10.1091/mbc.E09-02-0175. Epub 2009 May 20.

13.

Biomarker system for studying muscle, stem cells, and cancer in vivo.

Nishijo K, Hosoyama T, Bjornson CR, Schaffer BS, Prajapati SI, Bahadur AN, Hansen MS, Blandford MC, McCleish AT, Rubin BP, Epstein JA, Rando TA, Capecchi MR, Keller C.

FASEB J. 2009 Aug;23(8):2681-90. doi: 10.1096/fj.08-128116. Epub 2009 Mar 30.

14.

Dysferlin-deficient muscular dystrophy: gadofluorine M suitability at MR imaging in a mouse model.

Schmidt S, Vieweger A, Obst M, Mueller S, Gross V, Gutberlet M, Steinbrink J, Taubert S, Misselwitz B, Luedemann L, Spuler S.

Radiology. 2009 Jan;250(1):87-94. doi: 10.1148/radiol.2501080180. Epub 2008 Nov 10.

PMID:
19001151
15.

Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies.

Wallace GQ, McNally EM.

Annu Rev Physiol. 2009;71:37-57. doi: 10.1146/annurev.physiol.010908.163216. Review.

PMID:
18808326
16.

Animal models for genetic neuromuscular diseases.

Vainzof M, Ayub-Guerrieri D, Onofre PC, Martins PC, Lopes VF, Zilberztajn D, Maia LS, Sell K, Yamamoto LU.

J Mol Neurosci. 2008 Mar;34(3):241-8. doi: 10.1007/s12031-007-9023-9. Epub 2008 Jan 18. Review.

PMID:
18202836
17.

Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis.

Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C, Rando TA.

Science. 2007 Aug 10;317(5839):807-10.

18.

Histological and immunohistological changes of the skeletal muscles in older SJL/J mice.

Nemoto H, Konno S, Nakazora H, Miura H, Kurihara T.

Eur Neurol. 2007;57(1):19-25. Epub 2006 Nov 14.

PMID:
17108690
19.

Myogenic progenitor cells in the mouse embryo are marked by the expression of Pax3/7 genes that regulate their survival and myogenic potential.

Buckingham M, Bajard L, Daubas P, Esner M, Lagha M, Relaix F, Rocancourt D.

Anat Embryol (Berl). 2006 Dec;211 Suppl 1:51-6. Epub 2006 Oct 13. Review.

PMID:
17039375
20.

Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.

Ho M, Post CM, Donahue LR, Lidov HG, Bronson RT, Goolsby H, Watkins SC, Cox GA, Brown RH Jr.

Hum Mol Genet. 2004 Sep 15;13(18):1999-2010. Epub 2004 Jul 14.

PMID:
15254015

Supplemental Content

Support Center